FindTrial
Sign In

Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19)

Study on immune cell subsets in convalescent patients with SARS-CoV-2 infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030690
Enrollment
Unknown
Registered
2020-03-10
Start date
2020-02-10
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Two groups:Nil

Sponsors

The Third Affiliated Hospital of the Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: COVID-19 confirmed that the clinical symptoms of patients disappeared, after imaging examination, virus nucleic acid test, in line with the discharge criteria of convalescent patients.

Exclusion criteria

Exclusion criteria: 1) < 18 years old or = 80 years old; 2) pregnant and lactating women; 3) patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system.

Design outcomes

Primary

MeasureTime frame
Lymphocyte grouping;—

Countries

China

Contacts

Public ContactWang Hongyang

The Third Affiliated Hospital of the Second Military Medical University

hywangk@vip.sina.com+86 13801955367

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026